Lincomycin has good antibacterial activity against anaerobic bacteria, such as Clostridium, Enterococcus, Streptococcus, Clostridium tetanus, Clostridium perfringens and most actinomycetes. Lincomycin mainly acts on the 50S subunit of bacterial ribosomes and affects protein synthesis by inhibiting the elongation of peptide chain.